Document is current
Any future updates will be listed below
-
Authors
Powis, Melanie
Ladak, Aly M.
Lakey, Ashanté
Grant, Robert C.
Krzyzanowska, Monika K.
Peterson, Emily
Juliao, Kyle
-
Funding
Funding for this research was provided by:
Princess Margaret Cancer Foundation
- License Information
-
More Information
Article History
Received: 16 September 2025
Accepted: 23 April 2026
First Online: 8 May 2026
Competing interests
: Robert Grant has paid consulting or advisory roles for Astrazeneca, Eisai, Incyte, Knight Therapeutics, Guardant Health, and Ipsen, and an unpaid consulting role with Tempus. All other authors declare no competing interests.
